ASPEN PHARMACARE HOLDINGS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 216.3 ZAR | +1.20% |
|
-3.45% | +6.29% |
| Mar. 08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
| Mar. 05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Aspen Pharmacare Holdings Limited is the African leading pharmaceutical group. The group's products are primarily for the treatment of asthma, HIV, bacterial infections, gastro-intestinal, respiratory and inflammatory diseases. Net sales break down by family of products as follows:
- pharmaceuticals (71.6%): anaesthetics products, thrombosis products, cytotoxic products, etc.;
- other (28.4%): infant nutrition products and consumer products.
At the end of June 2022, the group had 16 production sites worldwide.
Sector
Pharmaceuticals
Calendar
2024-09-02
- Q4 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
216.3
ZAR
Average target price
232
ZAR
Spread / Average Target
+7.27%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +6.29% | 5.01B | |
| +20.90% | 42.78B | |
| +18.59% | 22.25B | |
| +14.56% | 14.39B | |
| +12.71% | 13.55B | |
| +37.98% | 11.27B | |
| -9.80% | 6.95B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| -8.24% | 4.51B |
- Stock Market
- Equities
- APN Stock
- News Aspen Pharmacare Holdings Limited
- South Africa's Aspen Pharmacare Secures $30 Million Funding to Manufacture Vaccines for Africa
